ResMed (NYSE:RMD) is preparing to release its quarterly earnings on Thursday, 2025-10-30. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect ResMed to report an earnings per share (EPS) of $2.50.

The market awaits ResMed's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Historical Earnings Performance

The company's EPS beat by $0.08 in the last quarter, leading to a 2.67% increase in the share price on the following day.

Here's a look at ResMed's past performance and the resulting price change:

Quarter

Q4 2025

Q3 2025

Q2 2025

Q1 2025

EPS Estimate

2.47

2.36

2.31

2.04

EPS Actual

2.55

2.37

2.43

2.20

Price Change %

3.00

10.00

-8.00

7.00

Stock Performance

Shares of ResMed were trading at $256.57 as of October 28. Over the last 52-week period, shares are up 5.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analysts' Take on ResMed

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on ResMed.

With 9 analyst ratings, ResMed has a consensus rating of Outperform. The average one-year ...